Document is current

Any future updates will be listed below

The Targets of Immune Adverse Events in Cancer Immunotherapy by Combined Check-point Inhibitors Resemble those Seen in IPEX Patients

Crossref DOI link: https://doi.org/10.1007/s10875-025-01929-4

Published Online: 2025-10-01

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark